13D Filing: Longitude Capital Partners, Llc and Corcept Therapeutics Inc (NASDAQ:CORT)

¹ Investment funds from limited
partners were used to acquire the securities over which the Reporting Persons have shared voting and dispositive power.

² Consists of 171,610 shares
of Common Stock held of record by Ms. Bakker.

³ Consists of 5,721,372 shares
of Common Stock held of record by LVP, 114,675 shares of Common Stock held of record by LCA and stock options to purchase up to
307,500 shares of Common Stock granted to Mr. Enright, all of which are currently exercisable or exercisable within 60 days
after March 17, 2017.

⁴ The percentage was calculated
based upon 113,249,891 shares of Common Stock outstanding, calculated as follows: the 112,942,391 shares of Common Stock outstanding
as of February 28, 2017, as reported by the Issuer in its Annual Report on Form 10-K filed with the Commission on March 6,
2017, plus the 307,500 shares of Common Stock subject to stock options granted to Mr. Enright that are exercisable as of or
within 60 days after March 17, 2017.